Hydrocodone cough suppressants will be taken off the market.

  The FDA will be pulling some unapproved hydrocodone cough suppressants from the market.

  The withdrawal mostly concerns hydrocodone cough preps with guaifenesin (Hycotuss, etc) or with homatropine PLUS an expectorant or decongestant (Histinex, etc).

  These drugs came on the market before proof of efficacy and safety was required. Some of the unapproved products are also labeled for use in children as young as 2-years-old, even though hydrocodone cough suppressants have not been proven safe or effective for children under 6-years-old.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote